A seven-day course of elamipretide, a four-amino-acid peptide that concentrates in the inner mitochondrial membrane, improved oocyte quality, fertilization rates, and litter size in aged mice, with parallel improvements observed in human oocytes in vitro. The treatment partially restored an aged ovarian metabolite profile, including pyruvate and Vitamin B6 metabolism, and reversed age-related changes in VEGF signaling. Ovarian function remains one of the earliest organ systems to decline, making it a sensitive readout of mitochondrial aging more broadly.
Key Points
- Seven-day elamipretide improved aged mouse oocyte quality and litter size
- Treatment reversed 250 age-shifted ovarian metabolites, including pyruvate
- Vitamin B6 supplementation alone also improved aged oocyte quality
Longevity Analysis
Ovarian decline begins decades before most other age-related failures, which positions the oocyte as an early sentinel for mitochondrial energy capacity across the whole organism. The mechanism here is instructive: restoring the efficiency of energy production, rather than adding a hormone or growth factor, was sufficient to recover function in cells long considered irreversibly aged. The Vitamin B6 finding is notable because it identifies a low-cost nutritional lever operating on the same metabolic node, suggesting that correcting upstream micronutrient and mitochondrial deficits deserves attention before more aggressive interventions.
Original published by LifeSpan.io, by Anna Drangowska-Way.